Ashfield, Niall
ORCID: 0000-0002-1536-5366
(2026)
Investigating combinations of tyrosine kinase inhibitors and antibody-drug conjugates, and mechanisms of resistance, in HER2-expressing breast cancers.
PhD thesis, Dublin City University.
Valenti, Marta (2025) Investigating the role of HER4 and HER4 mutations in cancer. PhD thesis, Dublin City University.
Castel, Myra (2025) Pre-clinical rationale for new indications and novel combinations of the tyrosine kinase inhibitor neratinib in cancer. PhD thesis, Dublin City University.